Início/Ações/CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$12.130

Máximo

$12.168

Mínimo

$11.230

Volume

0.56M

Fundamentos da empresa

Capitalização de mercado

191.2M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.27M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $4.64Atual $11.250Máximo $20.77

Notícias relacionadas

31/10/2025 · 06:40

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

Ver mais

Corbus Pharmaceuticals Announces Pricing of Public Offering

30/10/2025 · 20:31

GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

Ver mais

Corbus Pharmaceuticals Announces Proposed Public Offering

14/10/2025 · 12:00

GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

Ver mais